IGHV MUTATIONAL STATUS IN A COHORT OF BULGARIAN CLL PATIENTS: HIGH UNMUTATED CLL PREVALENCE IN NORTH-EAST BULGARIA
Yosifova A, Micheva I, Donchev M, Tincheva S, Ormandjiev S,
Genova J, Pavlova Z, Todorova A
*Corresponding Author: Angelina Yosifova, Genetic Medico-Diagnostic Laboratory “Genica”, Sofia,
Bulgaria. Email: andjim91@gmail.com; Phone: +359888979313
page: 15
|
|
REFERENCES
1. Rajendra ND, Tarun W, Franco F et al. Ig V Gene Mu-
tation Status and CD38 Expression As Novel Prog-
nostic Indicators in Chronic Lymphocytic Leukemia,
Blood, Volume 94, Issue 6, 1999, Pages 1840-1847.
2. Sutton, L. A., et al. Immunoglobulin genes in chronic
lymphocytic leukemia: Key to understanding the dis-
ease and improving risk stratification. Haematologica.
102 (6), 968-971 (2017).
3. Ten Hacken E, Gounari M, Ghia P et al. The im-
portance of B cell receptor isotypes and stereotypes
in chronic lymphocytic leukemia. Leukemia. 2019
Feb;33(2):287-298. doi: 10.1038/s41375-018-
0303-x. Epub 2018 Dec 16. PMID: 30555163; PM-
CID: PMC7182338.
4. Schroeder HW Jr, Cavacini L. Structure and func-
tion of immunoglobulins. J Allergy Clin Immunol.
2010 Feb;125(2 Suppl 2):S41-52. doi: 10.1016/j.
jaci.2009.09.046. PMID: 20176268; PMCID:
PMC3670108
5. Calis JJ, Rosenberg BR. Characterizing immune rep-
ertoires by high throughput sequencing: strategies and
applications. Trends Immunol. 2014;35(12):581–590.
6. Agathangelidis A, Chatzidimitriou A, Chatzikon-
stantinou T et al. Immunoglobulin gene sequence
analysis in chronic lymphocytic leukemia: the 2022
update of the recommendations by ERIC, the Euro-
pean Research Initiative on CLL. Leukemia 2022;
36, 1961–1968.
7. Huet, Sarah & Bouvard, Anne & Ferrant, Emmanuelle
& Mosnier, Isabelle & Chabane, Kaddour & Salles,
Gilles & Michallet, Anne-Sophie & Hayette, San-
drine & Sujobert, Pierre. (2020). Impact of using
leader primers for IGHV mutational status assess-
ment in chronic lymphocytic leukemia. Leukemia.
34. 10.1038/s41375-020-0716-1.
8. Agathangelidis A, Sutton LA, Hadzidimitriou A et al.
Immunoglobulin Gene Sequence Analysis In Chronic
Lymphocytic Leukemia: From Patient Material To
Sequence Interpretation. 2018 J. Vis. Exp. (141)
9. Matthews C, Catherwood M, Morris TC et al. Routine
analysis of IgVH mutational status in CLL patients
using BIOMED-2 standardized primers and proto-
cols. Leuk Lymphoma. 2004 Sep;45(9):1899-904.
10. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST:
the highly customized and integrated system for IG and
TR standardized V-J and V-D-J sequence analysis. Nucle-
ic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8.
11. Jain P, Nogueras Gonzalez GM, Kanagal-Shamanna
R. The absolute percent deviation of IGHV muta-
tion rather than a 98% cut-off predicts survival of
chronic lymphocytic leukaemia patients treated with
fludarabine, cyclophosphamide and rituximab. Br J
Haematol. 2018; 180(1):33-40.
12. Darzentas N. ARResT/Interrogate Immunoprofiling
Platform: Concepts, Workflows, and Insights. 2022
May 28. In: Langerak AW, editor. Immunogenet-
ics: Methods and Protocols [Internet]. New York:
Humana; 2022. Chapter 26. Available from: https://
www.ncbi.nlm.nih.gov/books/NBK586953/ doi:
10.1007/978-1-0716-2115-8_26;
13. Bystry V, Agathangelidis A, Bikos V et al, also on
behalf of ERIC, the European Research Initiative on
CLL, ARResT/AssignSubsets: a novel application
for robust subclassification of chronic lymphocytic
leukemia based on B cell receptor IG stereotypy, Bio-
informatics, Volume 31, Issue 23, December 2015,
Pages 3844–3846,
14. Gaidano G, Rossi D. The mutational landscape of
chronic lymphocytic leukemia and its impact on prog-
nosis and treatment. Hematology Am Soc Hematol
Educ Program. 2017 Dec 8;2017(1):329-337. doi:
10.1182/asheducation-2017.1.329. PMID: 29222275;
PMCID: PMC6142556.
15. Hanson C. GHV and TP53 Sequencing: Clinical
Utility in Chronic Lymphocytic Leukemia (CLL).
Available from: https://news.mayocliniclabs.
com/2019/08/12/ighv-and-tp53-sequencing-clinical-
utility-in-chronic-lymphocytic-leukemia-cll
16. Plevova K, Francova HS, Burckova K et al. Mul-
tiple productive immunoglobulin heavy chain gene
rearrangements in chronic lymphocytic leukemia are
mostly derived from independent clones. Haemato-
logica. 2014 Feb;99(2):329-38.
17. Rotbain EC, Frederiksen H, Hjalgrim H, et al.
IGHV mutational status and outcome for patients
with chronic lymphocytic leukemia upon treatment:
a Danish nationwide population-based study. Hae-
matologica. 2020 Jun;105(6):1621-1629
18. Gemenetzi K, Agathangelidis A, Zaragoza-Infante
L et al. B Cell Receptor Immunogenetics in B Cell
Lymphomas: Immunoglobulin Genes as Key to On-
togeny and Clinical Decision Making; Frontiers in
Oncology 10, 2020;
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
